AzTrials
AzTrials

Fracture of Metacarpal Bone1-2-KiWINCT01803789

Single Versus Double Kirschner Wires for Intramedullary Fixation of Metacarpal V Fractures

A study testing Single Kirschner Wire and Double Kirschner Wire in people with Fracture of Metacarpal Bone, run by University Medicine Greifswald at 12 sites in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Metacarpal V fractures are injuries of the upper extremities. They occur frequently, primarily in young adults.These fractures are caused by falling on the fist, sports accidents and direct or indirect forces. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Fracture of Metacarpal Bone
What is being tested?
Single Kirschner Wire and Double Kirschner Wire
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
292 participants
Where
12 sitesGermany
Study dates
May 2013to Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients ≥18 years with a metacarpal V neck fracture with a palmar angulation and/or shortening and /or rotational deformity as determined on radiological diagnosis
  • Trauma within 10 days before appearing in the study centre
  • No specific medical treatment before
  • Ability to fully understand the character and implications of the clinical trial
  • Written or oral (in case of an injury of the dominant hand, if so attested by witnesses)consent

Who cannot join

  • Indications for conservative therapy
  • Patient is not suitable for anaesthesia
  • Other physical conditions or characteristics which made surgical interventions inappropriate or to risky (e.g. open fractures, polytrauma, pregnancy, acute infections, pathological fractures)
  • Prior participation in this study (e.g. injury of the contralateral hand) or participation in other interventional studies with the same objective
  • Physical or mental diseases which makes the consequent participation in diagnostic, therapy and the follow-up-examinations unlikely
  • Lacking language skills

Trial locations and contacts

12 sites in 1 country.

12 sites in 1 country

Germany12 sites
  • Sana Clinical Centre Lichtenberg

    Berlin, 10365

  • Vivantes Hospital Am Urban

    Berlin, 10967

  • Trauma Hospital Berlin

    Berlin, 12683

  • University Medicine Düsseldorf

    Düsseldorf, 40225

  • University Medicine Greifswald

    Greifswald, Mecklenburg-Vorpommern, 17489

  • District Hospital Gummersbach

    Gummersbach, 51643

  • BG Kliniken Bergmannstrost

    Halle, 06112

  • Berufsgenossenschaftliches Unfallkrankenhaus Hamburg

    Hamburg, 21033

  • University Medicine Hamburg-Eppendorf

    Hamburg, 220246

  • Berufsgenossenschaftliches Unfallkrankenhaus Ludwigshafen

    Ludwigshafen, 67071

  • University Medicine Rostock

    Rostock, 18055

  • Municipal Clinic Solingen

    Solingen, 42663

Other trials in Germany

About this study

Metacarpal V fractures are injuries of the upper extremities. They occur frequently, primarily in young adults.These fractures are caused by falling on the fist, sports accidents and direct or indirect forces.

Surgical intervention is necessary for fractures with a strong palmar angulation of the metacarpal bone or rotational deformity of the small finger. Due to the absence of guideline recommendations decisions about therapy are made taking into account logistical aspects, available hardware, individual expertise and preferences. The objective of the study is to compare the advantages and disadvantages of single versus double Kirschner wires for intramedullary fixation of metacarpal V fractures in order to standardize national therapy procedures.

Read more

Primary hypothesis:

In the surgical therapy of the dislocated and/or rotational deformed metacarpal V neck fracture, osteosynthesis with a single Kirschner wire is not inferior to osteosynthesis with a double Kirschner wire with regard to the functional outcome after 6 month, as measured with the Disabilities of the Arm, Shoulder and Hands Score (DASH).

Being tested
Single Kirschner Wire, Double Kirschner Wire
Keywords
Metacarpal V Fractures, Single Kirschner Wires, Double Kirschner Wires

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Single Kirschner WireDevice

  • Double Kirschner WireDevice

Study groups in NCT01803789
Study groupRoleWhat they receive
Single Kirschner WireActive comparatorAntegrade intramedullary fixation of with a single Kirschner wire.
Receives: Device: Single Kirschner Wire
Double Kirschner WireActive comparatorAntegrade intramedullary fixation with double Kirschner wire.
Receives: Device: Double Kirschner Wire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in functional outcome of the therapy with single or double Kirschner wires measured with the DASH score

    Measured: 6 months after randomisation

Secondary outcomes (12)
  1. Malposition or angulation in the frontal and sagittal planes of max. 5°

    Measured: 6 months after randomisation

  2. Shortening of the metacarpus >2mm

    Measured: 6 months after randomisation

  3. Palmar angulation >30°

    Measured: 6 months after randomisation

  4. Non-union/Pseudarthrosis

    Measured: 6 months after randomisation

  5. Limitation of fist closure

    Measured: 6 months after randomisation

  6. Flexion or extension lag

    Measured: 6 months after randomisation

  7. Pain intensity <10 points (VAS)

    Measured: 6 months after randomisation

  8. Duration of surgical intervention

    Measured: 6 months after randomisation

  9. Rate of re-interventions

    Measured: 6 months after randomisation

  10. Rate of infections

    Measured: 6 months after randomisation

  11. Rate of perforation/dislocation/break of the fracture fixation devices

    Measured: 6 months after randomisation

  12. Duration of inability to work

    Measured: 6 months after randomisation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2013 (estimated)
  2. Study startMay 2013
  3. Primary completionJun 2017
  4. Study completionJul 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
292 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01803789
Sponsor's protocol ID
1-2-KiWI
Acronym
1-2-KiWI
Status last verified
Nov 2017
First submitted
1 Mar 2013
Last updated
6 Nov 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Single Kirschner Wire and Double Kirschner Wire in people with Fracture of Metacarpal Bone, run by University Medicine Greifswald at 12 sites in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 12 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in functional outcome of the therapy with single or double Kirschner wires measured with the DASH score (time frame: 6 months after randomisation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in